It would be dubious to seriously estimate the need now for the future and it is not possible to give exact figures. The fact is, however, that the demand is growing and will be huge, the more manganese sulfate becomes an important component of future batteries.
- Forums
- ASX - By Stock
- E25
- Ann: HPMSM Feasibility Study Update
E25
element 25 limited
Add to My Watchlist
7.14%
!
22.5¢

Ann: HPMSM Feasibility Study Update, page-54
Featured News
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
|
|||||
Last
22.5¢ |
Change
0.015(7.14%) |
Mkt cap ! $51.43M |
Open | High | Low | Value | Volume |
22.0¢ | 22.5¢ | 21.5¢ | $36.91K | 166.7K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
1 | 11163 | 22.0¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
22.5¢ | 101483 | 3 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
1 | 11163 | 0.220 |
4 | 65606 | 0.215 |
4 | 14875 | 0.210 |
1 | 3107 | 0.205 |
8 | 89405 | 0.200 |
Price($) | Vol. | No. |
---|---|---|
0.225 | 101483 | 3 |
0.230 | 72958 | 1 |
0.235 | 124800 | 3 |
0.240 | 252084 | 2 |
0.245 | 21276 | 1 |
Last trade - 16.10pm 26/06/2025 (20 minute delay) ? |
Featured News
E25 (ASX) Chart |
The Watchlist
PTX
PRESCIENT THERAPEUTICS LIMITED
James McDonnell, CEO
James McDonnell
CEO
Previous Video
Next Video
SPONSORED BY The Market Online